ASCIA Action Plans for Anaphylaxis

The following 2018 versions of ASCIA Action Plans are the latest versions and are valid for use throughout 2019, until the 'due for review date' on the plan.  A 2017 version is also valid if the 'due for review date' is in 2018 or later.

ASCIA Action Plans have been developed as an easy to follow, single page document to assist in emergency treatment of anaphylaxis. The plans are medical documents that can be completed online and saved as PDFs, by the treating medical or nurse practitioner. After typing patient details into the text fields, "save as" and save with a new name (e.g. patient name).

ASCIA Action Plan for Anaphylaxis personal for use with EpiPen

ASCIA Action Plan for Anaphylaxis (personal) for use with EpiPen 2018

pdfASCIA Action Plan for Anaphylaxis (personal) for use with EpiPen369.93 KB 

ASCIA Action Plan for Anaphylaxis personal for use with autoinjectors

ASCIA Action Plan for Anaphylaxis (personal) for use with any brand of adrenaline autoinjector 2018 

pdfASCIA Action Plan for Anaphylaxis (personal) for use with adrenaline autoinjectors265.79 KB

ASCIA Action Plan for Allergic Reactions (personal)

ASCIA Action Plan for Allergic Reactions (personal) for use when no adrenaline autoinjector has been prescribed 2018 

pdfASCIA Action Plan for Allergic Reactions (personal)238.61 KB

The following 2018 version of the ASCIA Action Plan (general) can be used as a poster or in first aid kits

ASCIA Action Plan for Anaphylaxis general for use with EpiPen

ASCIA Action Plan for Anaphylaxis (general) for use with EpiPen 2018

pdfASCIA Action Plan for Anaphylaxis (general) for use with EpiPen267.57 KB

ASCIA Action Plan for Anaphylaxis general for use with autoinjectors

ASCIA Action Plan for Anaphylaxis (general) for use with any brand of adrenaline autoinjector 2018

pdfASCIA Action Plan for Anaphylaxis (general) for use with auotinjectors198.95 KB

Important information:

1. ASCIA Action Plans should be reviewed and reissued when patients are reassessed by their doctor, and each time they obtain a new adrenaline autoinjector prescription, which is approximately every 12 to 18 months. If there are no changes in diagnosis or management the medical information on the ASCIA Action Plan may not need to be updated. However, if the patient is a child, the photo should be updated each time, so they can be easily identified.

2. ASCIA Action Plans for Anaphylaxis can be used for individuals with food and insect allergies (ASCIA Action Plans specific for Insect Allergy were discontinued in March 2011).

3. ASCIA Action Plans for Anaphylaxis include instructions on how to use an adrenaline autoinjector and should therefore always be stored with the autoinjector.

4. Adrenaline autoinjectors contain a single, fixed dose of adrenaline and are designed to be used by anyone (medical training is not required), including friends, teacher, childcare worker, parents or patients (if they are not too unwell or too young).

5. It is generally recommended that individuals who carry an adrenaline autoinjector should also wear a medical identification/emergency response emblem  or other medical identification.

6. ASCIA Action Plans should be used as part of a comprehensive anaphylaxis management plan that includes:


Content updated April 2019